BioCryst deepens rare diseases focus with $700 million deal for Astria - Reuters

Reuters | Oct. 14, 2025, 9:17 a.m. | Original
BioCryst deepens rare diseases focus with $700 million deal for Astria Reuters
European growth to hold up but at an increasing fiscal cost, IMF says - Reuters Long Treasury yields to stay elevated as inflation, debt pressures blunt Fed easing: Reuters poll - Reuters